tHEORetically Speaking - health economics Archives

Podcast Q&A: Improving the Representativeness of Research

April Rieger2024-04-01T13:24:40-04:00April 12th, 2023|Categories: Blog, Podcasts|Tags: clinical research, clinical trials, health economics, outcomes research, Real world data, real world evidence, RWE, tHEORetically Speaking|

This podcast segment features the Q&A from Cardinal Health's March 23, 2023 webinar with HealthEconomics.Com. Join Dr. Bruce Feinberg, Dr. [...]

Get to Know R-S-S (Regulatory Scientific and Health Solutions)

April Rieger2024-04-01T13:24:41-04:00March 6th, 2023|Categories: Blog|Tags: health economics, HTA, market access, real world evidence, tHEORetically Speaking|

Supplier Spotlight® highlights the unique skills and services offered by organizations that are part of our CONNECTED COMMUNITY™. [...]

Podcast Q&A: HEOR for Medical Technologies for the US Healthcare System

April Rieger2023-11-15T18:41:44-05:00December 31st, 2022|Categories: Blog, Podcasts|Tags: health economics, HEOR, medical technology, outcomes research, pharma, Real world data, tHEORetically Speaking|

This podcast segment features the Q&A from Alira Health's December 14, 2022 webinar and features Deepak Sahu, MBA, MPH [...]

Foundation of Sand

April Rieger2024-04-01T13:25:47-04:00March 23rd, 2022|Categories: Blog|Tags: Epidemiology, health economics, health outcomes, HEOR, ICD Codes, outcomes research, Pharmaceutical Industry, Real world data, real world evidence, RWD, tHEORetically Speaking|

The last decade has seen an explosion of interest in and production of real world evidence (RWE). But I’m afraid there is a day of reckoning approaching.

MArS Supplier Spotlight

April Rieger2023-12-14T13:15:55-05:00March 21st, 2022|Categories: Blog|Tags: Austria, Germay, health economics, market access, payers, pharmaceutical, podcast, pricing, reimbursement, Switzerland, tHEORetically Speaking, value communications|

Supplier Spotlight® highlights the unique skill sets and service offerings from organizations who are part of our CONNECTED COMMUNITY™. Below [...]

How Should a Safe and Effective COVID‑19 Vaccine be Allocated? Health Economists Need to be Ready to Take the Baton

April Rieger2023-11-15T12:40:33-05:00September 28th, 2020|Categories: Blog|Tags: Coronavirus, Cost Effectiveness Analysis, COVID-19, health economics, Randomized Control Trials, tHEORetically Speaking, Vaccine|

Recently, there have been encouraging commitments around the world to manufacture coronavirus disease 2019 (COVID-19) vaccines in anticipation of results from clinical studies.

JHE Editors Honor Wagstaff

Sydney Otomancek2020-05-27T07:51:51-04:00May 27th, 2020|Categories: Featured, Industry News|Tags: Adam Wagstaff, health economics, Healtheconomics.com, HEOR, JHE, Journal of Health Economics|

The Journal of Health Economics is offering free access to the late Adam Wagstaff's contributions. Wagstaff had 24 full articles [...]

Hatswell Considers Impact of COVID-19 on Health Economics

Sydney Otomancek2020-05-03T08:46:46-04:00May 3rd, 2020|Categories: Featured, Industry News|Tags: Anthony Hatswell, health economics, Healtheconomics.com, HEOR|

In a recent editorial, Delta Hat's Anthony Hatswell considers the implications for the health economics landscape in the midst of [...]

Article Spotlights Amy Finkelstein

Sydney Otomancek2020-04-27T09:31:53-04:00April 27th, 2020|Categories: Featured, Industry News|Tags: Amy Finkelstein, health economics, Healtheconomics.com, HEOR|

A recent MIT Technology Review article spotlights the impact health economist Amy Finkelstein has had on the understanding of, among [...]

ICER Taps Campbell as Senior VP for Health Economics

Sydney Otomancek2023-10-10T17:15:17-04:00April 23rd, 2020|Categories: HEOR Feature, Industry News|Tags: health economics, Healtheconomics.com, HEOR, ICER, Institute for Clinical and Economic Review, Jonathan Campbell|

The Institute for Clinical and Economic Review (ICER) on Thursday, April 23, announced the appointment of Jonathan Campbell as the [...]

New iHEA Blog Looks to Facilitate Collaboration on Teaching, Training

Sydney Otomancek2020-04-13T08:08:16-04:00April 13th, 2020|Categories: Featured, Industry News|Tags: health economics, Healtheconomics.com, HEOR, iHEA|

The iHEA Teaching Health Economics Special Interest Group is launching a new blog that aims to facilitate collaboration among health [...]

Petition: Allow Registered Reports for Peer Review

Sydney Otomancek2020-02-10T12:52:39-05:00February 10th, 2020|Categories: Featured, Industry News|Tags: Change.Org, health economics, health economists, Healtheconomics.com, HEOR, Peer Review, registered reports|

A petition on Change.Org is calling for health economics journals to allow registered reports for peer-review. As of this posting, [...]

HEOR Salaries: Big Growth in Certain Sectors. Where Do You Stand?

April Rieger2023-11-15T17:43:05-05:00November 8th, 2017|Categories: Blog, HEOR Feature|Tags: careers, health economics, health outcomes, HEOR, HEOR careers, salary survey, tHEORetically Speaking|

2017 HEOR & Market Access Salaries show big growth in key areas of Pricing, Market Access, and HEOR-focused Medical Communications. [...]

Industry Groups Challenge Readiness of ICER’s Value Framework

April Rieger2023-11-14T18:40:41-05:00November 30th, 2016|Categories: Blog|Tags: Big Data, evidence-based medicine, health economics, HEOR, Patti Peeples, pepperslice, Pharmaceutical Industry, real world evidence, tHEORetically Speaking, tracy allison altman, value assessment frameworks|

Healthcare is all about making decisions. Who to treat? When to treat? How to treat? How long to treat? How [...]

An Englishman in New York

April Rieger2023-11-15T13:08:14-05:00November 29th, 2016|Categories: Blog, HEOR Feature|Tags: andrew briggs, health economics, health outcomes, HEOR, market access, pharmaceutical, pricing, tHEORetically Speaking|

Part I: A letter from America. by Professor Andrew Briggs "A cynic knows the price of everything but the [...]

Sex Reassignment Surgery For Transgenders: Should It Be Covered By Health Insurance?

April Rieger2023-11-15T18:57:21-05:00September 9th, 2016|Categories: Blog|Tags: gender reassignment, health economics, Healtheconomics.com, payers, tHEORetically Speaking, Transgender|

People who identify themselves as transgender evolved in their belief of a gender-assignment mistake when they are self-aware of stereotypes [...]

A Case for Better Health Care Economics Education in the United States

April Rieger2023-11-15T13:08:14-05:00June 6th, 2016|Categories: Blog, HEOR Feature|Tags: Education, graduate education, health economics, HEOR, tHEORetically Speaking, Washington & Jefferson|

Reynold W. (Pete) Mooney About a year ago I had an informal meeting with several CEO acquaintances. One [...]

A Brief History of Diabetes Simulation Modelling and the Mt Hood Challenge

April Rieger2023-12-14T13:11:10-05:00May 17th, 2016|Categories: Blog|Tags: decision analysis, diabetes, health economics, philip clarke, real world evidence, simulation modeling, tHEORetically Speaking, university of melbourne|

Why is a diabetes and economics simulation modelling conference named after a mountain? Back in 1999, two groups who developed [...]

Paying for Specialty Pharmaceuticals: The Case of Injectable Oncology Drugs

April Rieger2023-11-15T13:48:59-05:00August 4th, 2015|Categories: Blog|Tags: Avalon Health Economics, drug cost, health economics, inpatient costs, medical costs, oncology, oncology drugs, payers, tHEORetically Speaking|

John Schneider, Ph.D According to the American Cancer Society, the financial costs of cancer are high for both [...]

WHEN 1+1=3: HOW ELECTRONIC HEALTH RECORDS AND CLAIMS CAN BE USED SYNERGISTICALLY

April Rieger2023-12-14T13:11:14-05:00April 30th, 2015|Categories: Blog|Tags: administrative claims databases, Big Data, clinical trials, DaVita Clinical Research, Health Economic Models, health economics, health outcomes models, Healtheconomics.com, payers, real world evidence, RWE, tHEORetically Speaking|

Sponsored blog posting by DaVita Clinical Research. 1. Combining Drug Development with Real-World Data Analytics DaVita Clinical Research® (DCR®), a [...]